A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy

The adoptive transfer of chimeric antigen receptor (CAR) T cell represents a highly promising strategy to fight against multiple cancers. The clinical outcome of such therapies is intimately linked to the ability of effector cells to engraft, proliferate, and specifically kill tumor cells within pat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Ther
Päätekijät: Valton, Julien, Guyot, Valérie, Marechal, Alan, Filhol, Jean-Marie, Juillerat, Alexandre, Duclert, Aymeric, Duchateau, Philippe, Poirot, Laurent
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2015
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4817890/
https://ncbi.nlm.nih.gov/pubmed/26061646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2015.104
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia